J0887 Epoetin beta esrd use
Also known as: NeoRecormon, epoetin beta, ESA
Epoetin beta injection for patients with end-stage renal disease, an erythropoiesis-stimulating agent for anemia management in dialysis.
In Plain Language
Medicine to increase red blood cells in kidney disease
Clinical Context
Used for treatment of anemia in patients with end-stage renal disease on hemodialysis or peritoneal dialysis.
RVU Information
CPT J0887 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J0887?
CPT J0887 (Epoetin beta esrd use) is a J Codes (Drugs) code. Epoetin beta injection for patients with end-stage renal disease, an erythropoiesis-stimulating agent for anemia management in dialysis.
How is J0887 administered?
CPT J0887 is administered by a healthcare provider, typically via injection or infusion. Used for treatment of anemia in patients with end-stage renal disease on hemodialysis or peritoneal dialysis. It is used by Nephrology, Dialysis, Internal Medicine.
When is CPT J0887 used?
Used for treatment of anemia in patients with end-stage renal disease on hemodialysis or peritoneal dialysis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.